Association between systemic immune-inflammation index and disability among Polish ischemic stroke patients receiving intravenous thrombolysis: a single-center, prospective cohort study
Journal Title: International Neuroscience Conference (NEURO-2023) - Year 2023, Vol 4, Issue 1
Abstract
The inflammatory response plays a central role in the pathophysiology of ischemic stroke. One of the newest laboratory markers with potential for predicting the outcomes of ischemic stroke patients is the systemic immune-inflammation index (SII), but knowledge of its actual utility is limited. This prospective cohort study aimed to assess the association of SII with disability in ischemic stroke patients.The study included 51 patients who were diagnosed with ischemic stroke and qualified for intravenous thrombolysis. Before therapy, upon admission to the hospital, each patient underwent complete blood count, based on which the SII was calculated as the product of the count of platelets (P) and the count of neutrophils (N), divided by the count of lymphocytes (L); SII = P x N/L. The disability of patients was assessed using the modified Rankin Scale (mRS) on days 7, 30, and 90 after admission to the hospital. Patients were divided into two subgroups depending on mRS: those who were independent (mRS = 0-1) and those who showed any degree of dependence (mRS = 2-5). Nineteen women and 32 men with a median age of 70 years who underwent intravenous thrombolysis for ischemic stroke were included in the study. On day 7 after hospital admission, mRS was assessed in all patients, and on days 30 and 90, in 49 and 40 patients, respectively. Statistical analysis by the Mann-Whitney U test demonstrated no significant differences in SII between patients with mRS = 0-1 and patients with mRS = 2-5 at each time point (median SII = 531.3 vs. 469.8, p = 0.92; median SII = 509.3 vs. 535.9, p = 0.68; median SII = 473.8 vs. 443.3, p = 0.85, on days 7, 30 and 90, respectively). The area under the receiver operating characteristic curve (AUC-ROC) confirmed no relationship between SII and mRS on days 7, 30, and 90 after the patient’s admission to the hospital. In conclusion, our study found no relationship between SII and mRS in ischemic stroke patients who have undergone intravenous thrombolysis. Further research is needed, expanding the size of the study group and the diversity of ischemic stroke therapy.
Authors and Affiliations
Artur Słomka, Iga Kwiatkowska, Agata Bloch, Magdalena Sury, Urszula Rosińska, Małgorzata Wiszniewska, Ewa Żekanowska
Keywords
Related Articles
- EP ID EP747395
- DOI -
- Views 29
- Downloads 0
Role of probiotics in gut brain axis and management of neurodegenerative disorders
Introduction: The gut-brain axis (GBA) is a complex mechanism between the gut and the brain that regulates several physiological functions like metabolism and immunity regulated by gut flora and hormones along with immun...
Comparative assessment of microvascular decompression and gamma knife radiosurgery for trigeminal neuralgia: efficacy in pain alleviation and complication profiles
Introduction: Trigeminal neuralgia (TN) represents an infrequent yet highly distressing condition characterized by unilateral, electric shock-like facial pain triggered even by the gentlest stimuli. In the therapeutic la...
The effects of Minocycline on the neurological and inflammatory factors expression after severe traumatic brain injury in male rats: A molecular and histological study
Introduction: Traumatic brain injury (TBI) is a very complex disorder that includes different degrees of brain contusion, diffuse axonal damage, haemorrhage, and hypoxia. Minocycline is an antibiotic that acts through an...
The antineuroinflammation effects of Nimodipine after severe traumatic brain injury in male rat
Introduction: Nimodipine is a dihydropyridine calcium channel antagonist that blocks extracellular calcium currents through L-type and voltage-gated calcium channels. The use of calcium channel blockers has been suggeste...
Beneficial effects of levetiracetam in streptozotocin-induced rat model of Alzheimer’s disease
Alzheimer’s disease (AD) is the most common neurodegenerative disorder among the elderly. In the light of increasing AD prevalence and lack of effective treatment, new strategies to prevent or reverse this condition are...